CytoDyn
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$49,841,000 over the previous period. Total operating expenses were $18,058,000.

Profit Margin

CytoDyn Inc. (OTC:CYDY): Profit margin
2015 0 -25.92M
2016 0 -25.70M
2017 0 -25.76M
2018 0 -48.45M
2019 0 -56.18M
2020 0 -141.78M
2021 0 -174.01M
2022 266K -288.16M -108331.95%
2023 0 -79.82M
2024 0 -49.84M

CYDY Income Statement (2015 – 2024)

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Revenue
Revenue
00266K0000000
Cost of revenue
29K175K53K1.79M2.03M1.24M0366.38K00
Gross profit
-29K-175K213K-1.79M-2.03M-1.24M0-366.38K00
Operating exp.
Research and development
7.24M2.63M27.04M58.43M52.63M42.49M38.22M20.20M13.73M15.15M
Selling and marketing
017.11M00000000
Total operating expenses
18.05M40.40M72.12M94.54M74.64M55.85M45.91M27.33M21.17M19.59M
Operating income
-18.05M-40.57M-71.91M-104.59M-74.64M-55.85M-45.91M-27.33M-21.17M-19.59M
Other income (expenses), net
-31.78M-39.24M-138.90M-50.07M-49.75M-3.16M-4.23M1.56M135.22K-5.49M
Income before tax
-49.84M-79.82M-210.82M-154.67M-124.40M-59.01M-50.14M-25.76M-25.70M-25.08M
Income tax expense
012.99M77.34M19.34M17.37M-2.82M-1.69M-2.16M-62.32K838.64K
Net income
-49.84M-79.82M-288.16M-174.01M-141.78M-56.18M-48.45M-25.76M-25.70M-25.92M
Earnings per share
Basic EPS
-0.05-0.09-0.43-0.3-0.34-0.21-0.28-0.19-0.27-0.44
Diluted EPS
-0.05-0.09-0.43-0.3-0.34-0.21-0.28-0.19-0.27-0.44
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source